We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Momenta Pharmaceuticals Inc | NASDAQ:MNTA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 52.48 | 47.70 | 52.45 | 0 | 01:00:00 |
Delaware
|
|
04-3561634
|
(State or other jurisdiction of incorporation or
organization) |
|
(I.R.S. Employer Identification No.)
|
675 West Kendall Street
Cambridge, Massachusetts
|
|
02142
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Large accelerated filer
x
|
Accelerated filer
o
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
Smaller reporting company
o
|
|
Emerging growth company
o
|
|
|
|
|
|
|
|
|
|
|
||
Title of securities to be registered
|
|
Amount
to be registered(1) |
|
Proposed
maximum offering price per share(4) |
|
Proposed
maximum aggregate offering price(4) |
|
Amount of
registration fee |
|
||
Common stock, par value $0.0001 per share
|
|
1,400,000(2)
|
|
|
$16.30
|
|
$22,820,000
|
|
|
$2,644.84
|
|
Common stock, par value $0.0001 per share
|
|
4,300,000(3)
|
|
|
$16.30
|
|
$70,090,000
|
|
|
$8,123.44
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2)
|
Consists of an additional 1,400,000 shares issuable under the Momenta Pharmaceuticals, Inc. 2004 Employee Stock Purchase Plan, as amended and restated (the “ESPP”).
|
|
MOMENTA PHARMACEUTICALS, INC.
|
|
|
|
|
|
By:
|
/s/ Craig A. Wheeler
|
|
Name: Craig A. Wheeler
|
|
|
Title: President and Chief Executive Officer
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ Craig A. Wheeler
|
|
President, Chief Executive Officer and Director
|
|
August 7, 2017
|
|
Craig A. Wheeler
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
|
/s/ Scott M. Storer
|
|
Senior Vice President and Chief Financial Officer
|
|
August 7, 2017
|
|
Scott M. Storer
|
|
(Principal Financial and Accounting Officer)
|
|
|
|
|
|
|
|
|
|
/s/ James R. Sulat
|
|
Chairman of the Board and Director
|
|
August 7, 2017
|
|
James R. Sulat
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Bruce L. Downey
|
|
Director
|
|
August 7, 2017
|
|
Bruce L. Downey
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Corey N. Fishman
|
|
Director
|
|
August 7, 2017
|
|
Corey N. Fishman
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Georges Gemayel
|
|
Director
|
|
August 7, 2017
|
|
Georges Gemayel
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Steven C. Gilman
|
|
Director
|
|
August 7, 2017
|
|
Steven C. Gilman
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Jose-Carlos Gutiérrez-Ramos
|
|
Director
|
|
August 7, 2017
|
|
Jose-Carlos Gutiérrez-Ramos
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Thomas P. Koestler
|
|
Director
|
|
August 7, 2017
|
|
Thomas P. Koestler
|
|
|
|
|
|
|
|
|
|
|
|
/s/ Elizabeth Stoner
|
|
Director
|
|
August 7, 2017
|
|
Elizabeth Stoner
|
|
|
|
|
Exhibit
Number |
|
Description
|
|
|
|
4.1(1)
|
|
Third Amended and Restated Certificate of Incorporation of the Registrant
|
|
|
|
4.2(2)
|
|
Certificate of Designations of Series A Junior Participating Preferred Stock, dated November 8, 2005
|
|
|
|
4.3(3)
|
|
Fourth Amended and Restated By-laws of the Registrant
|
|
|
|
4.4(4)
|
|
Specimen certificate evidencing shares of common stock of the Registrant
|
|
|
|
5.1
|
|
Opinion of Latham & Watkins LLP
|
|
|
|
23.1
|
|
Consent of Ernst & Young LLP
|
|
|
|
23.2
|
|
Consent of Latham & Watkins LLP (included in Exhibit 5.1)
|
|
|
|
24.1
|
|
Power of Attorney (included on signature page)
|
|
|
|
99.1(5)
|
|
Momenta Pharmaceuticals, Inc. 2013 Incentive Award Plan (as amended and restated)
|
|
|
|
99.1(6)
|
|
Momenta Pharmaceuticals, Inc. 2004 Employee Stock Purchase Plan (as amended and restated)
|
1 Year Momenta Pharmaceuticals Chart |
1 Month Momenta Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions